Thermo Fisher Scientific and PRECISE Partner on Singapore Proteomics Study
The collaboration will use multi-omic platforms and AI-driven analytics to identify disease patterns and improve patient stratification within the PRECISE-SG100K study.
The collaboration will use multi-omic platforms and AI-driven analytics to identify disease patterns and improve patient stratification within the PRECISE-SG100K study.
The system combines enhanced sensitivity with automation to detect M-proteins at low concentrations, supporting early diagnosis of plasma cell disorders.
Finding themselves in a vicious tug-of-war, clinical labs are struggling to keep pace with emerging designer drugs.
Thermo Fisher Scientific unveiled advanced mass spectrometry instruments—Orbitrap Astral Zoom MS and Orbitrap Excedion Pro MS.
This collaboration aims to advance a smartphone-based hemoglobin test for accessible diagnostics of anemia and other health conditions.
Researchers have developed a blood-based proteomics model that accurately predicts disease progression in ADPKD.